Abstract
The United Kingdom’s National Institute for Health and Care Excellence guidance on implantable cardiac defibrillator (ICD) therapy recommend ICD in those with left ventricular dysfunction and a high risk of sudden cardiac death (SCD). SCD accounts for 30% deaths in non-ischaemic dilated cardiomyopathy (DCM), however risk stratifying and predicting SCD in DCM is a major management challenge. We present two cases demonstrating the potential role of cardiac magnetic resonance imaging in risk stratifying DCM.
Original language | English |
---|---|
Article number | A1 |
Pages (from-to) | 89-90 |
Number of pages | 2 |
Journal | Open Cardiovascular Medicine Journal |
Volume | 9 |
DOIs | |
Publication status | Published - 2015 |
Keywords
- Dilated Cardiomyopathy
- Fibrosis
- Magnetic Resonance Imaging
- Sudden Cardiac Death
- Ventricular Tachycardia